Cnat stock price target
CNAT stock: Conatus Pharmaceuticals Inc - Super Stock Screener Conatus Pharmaceuticals Inc's stock rating is based on fundamental analysis. Don't miss CNAT stock next rating changes Analysts Have Mixed Ratings On SunOpta Inc. (NASDAQ:STKL ... ROTH Capital also rated CNAT as Initiated on February 08, 2018, with its price target of $20 suggesting that CNAT could surge by 76.25% from its current share price. Even though the stock has been trading at $0.41/share, analysts expect it to down by -5.98% to reach $1.60/share. Conatus Pharmaceuticals Inc. (CNAT) Stock Price, Quote ... Conatus Pharmaceuticals Inc. (CNAT) and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly-owned subsidiary of Conatus in an all-stock Stifel slashes price target on Conatus Pharmaceuticals Inc ...
31 Jan 2020 The 1-year high price for the company's stock is recorded $3.08 on 03/21/19, with The Analysts eye on Conatus Pharmaceuticals Inc. (CNAT).
CNAT - Conatus Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Conatus Pharmaceuticals stock price target cut to $12 from $20 at SunTrust RH MarketWatch. 07:40 AM ET. Conatus Pharmaceuticals stock price target cut to $4 from $10 at Stifel Nicolaus MarketWatch. 07:39 AM ET. Conatus Pharmaceuticals Inc. (CNAT) stock price, quote ... Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue Estimates. Conatus (CNAT) delivered earnings and revenue surprises of 16.67% and -48.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? Conatus Pharmaceuticals (NASDAQ:CNAT) Analyst Ratings ...
Add CNAT Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+
Is Conatus Pharmaceuticals Inc. (CNAT) Dependable ...
Jan 30, 2020 · The new note on the price target was released on February 08, 2018, representing the official price target for Conatus Pharmaceuticals Inc. stock. Previously, the target price had yet another drop from $18 to $17, while H.C. Wainwright kept a Buy rating on CNAT stock.
Conatus Pharmaceuticals Inc. Common Stock (CNAT) Stock ... Conatus Pharmaceuticals Inc. Common Stock (CNAT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
View Price Target for CNAT Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
See Conatus Pharmaceuticals price target based on analysts offering 12 month price targets for Conatus Pharmaceuticals in the last 3 months. Follow CNAT to track price target and stock forecast updates from top wall street analysts. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Analyst ... Based on analysts offering 12 month price targets for CNAT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your Conatus Pharmaceuticals Inc. (CNAT) Stock Price, Quote ...
Nov 06, 2019 · Conatus Pharmaceuticals Inc. analyst estimates by MarketWatch. View CNAT revenue estimates and earnings estimates, as well as analyst recommendations. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Stock ...